Wall Street Journal April 15th 2008
http://online.wsj.com/article_email/SB1 ... TU4Wj.html
Rituxan Joins List of Treatments That Fail for Severe Form of MS
By KEITH J. WINSTEIN
April 15, 2008; Page B9
Rituxan, a top-selling drug from Genentech Inc. and Biogen Idec Inc., failed to slow the course of the most severe form of multiple sclerosis in a large study, the companies said.
The findings make Rituxan at least the sixth ...